Clinical trials

  • INFLUENZA A (H1N1/WSN/1933) NUCLEOPROTEIN FUSED TO C-TERMINAL FRAGMENTS OF TWO AVIAN C4BP ALFA CHAIN SEQUENCES for Influenza
  • Atezolizumab for Hepatocellular carcinoma (unresectable)
  • Atezolizumab for Soft tissue sarcoma | Localised and operable soft tissue sarcoma
  • LIDOCAINE HYDROCHLORIDE MONOHYDRATE for Anorexia nervosa
  • Cobimetinib for Advanced/metastatic soft tissue sarcoma | Rhabdomyosarcoma | Malignant peripheral nerve sheath tumor | Complex genomics sarcoma | Single genomic sarcoma
  • ALANINE, ARGININE, DEFEROXAMINE, HISTIDINE, ASPARTIC ACID, GLYCINE, TRYPTOPHAN, SUCROSE, CALCIUM, MAGNESIUM, POTASSIUM, SODIUM, N-HYDROXY-3,4-DIMETHOXY-N-METHYL-BENZAMIDE, N-ACETYLHISTIDINE, CHLORIDE ION, OXOGLURIC ACID for Heart transplantation
  • HDM201 for Advanced/metastatic soft tissue sarcoma
  • REM-422 (MYB mRNA degrader) for Relapsed/refractory acute myeloid leukaemia|Higher-risk myelodysplastic syndrome
  • TUCATINIB for HER2-positive metastatic breast cancer with isolated brain progression
  • ETENTAMIG for Multiple myeloma
  • Propofol for External cephalic version
  • ASCORBIC ACID for Cardiac surgery (open-heart surgery) | Cardiovascular disease